14:49 EST Nasus Pharma (NSRX) Ltd trading halted, volatility trading pause
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NSRX:
- Nasus Pharma Calls March 5 Special Meeting to Boost Share Capital and Approve New Equity Incentives
- Nasus Pharma Reports Strong Interim Phase 2 Data for Intranasal Epinephrine NS002
- Nasus Pharma announces results from Phase 2 study of NS002
- Nasus Pharma Reports Wider Interim Loss and Deepening Shareholders’ Deficit in June 2025 Results
- Nasus Pharma Highlights Transformational 2025 as NS002 Intranasal Epinephrine Program Advances and IPO Completes